Biotech

Another company with Wisconsin ties is part of a major acquisition, but this time the Wisconsin-linked company is the buyer. The London-based GE healthcare, which has a key facility in Waukesha, has purchased the core laboratory diagnostic units of Abbott Laboratories. The acquisition, which is...

Cytochroma, a Canadian biotechnology firm that plans to open a facility in Madison in 2007, has raised $21 million in venture capital to start clinical trials for its vitamin D products. The firm is managed by former employees of Bone Care International who are being...

In order to show that a corporate officer or director is personally liable for infringing intellectual property, a plaintiff has to meet a different standard for copyright, trademark, and patent infringement. While the bar is set high for each standard, corporate officers and directors must...

The Medical College of Wisconsin and Children's Hospital and Health System have dedicated a new biomedical research facility. The collaborative project will provide shared research space for Children's Research Institute and the Medical College's Translational and Biomedical Research Center. ...

Scott Converse believes he has his finger on the pulse of information technology workforce development issues, and as director of technology programs for the University of Wisconsin-Madison Business School, he has been involved in revamping programs for technology professionals. The latest trend, he explains, is...

Wisconsin’s women entrepreneurs will have an opportunity to be part of the Make Mine a Million business program, which seeks to inspire one million American women business owners to reach the $1 million revenue level by 2010. Wisconsin is the first state to hold a...

While 2006 was a good year for the overall stock market, it was less kind to the biotech sector and a real mixed bag for the large-cap life science companies in the Midwest. How was it for the far more speculative and risky smaller-cap companies?...

Third Wave Technologies and Digene Corp. are back in court, this time for a dispute over a patent covering a single type of the human papilloma virus. Digene is suing Third Wave, which denies that it's in violation of the patent, in the U.S. District...